Vitrolife AB (VITR):企業の財務・戦略的SWOT分析

◆英語タイトル:Vitrolife AB (VITR) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14919
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥44,400見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Vitrolife AB (Vitrolife) is a developer, producer and marketer of laboratory products. The company provides products such as Oocyte retrieval needles, sperm processing, culture media, culture oil, additional culture media, micromanipulation solutions, vitrolife labware, micromanipulation pipettes, and others. It offers products such as time lapse system, vitrification, slow freezing, octax laser and imaging system, log and guard, fertiproof and embryo biopsy. Vitrolife provides products for the preparation, cultivation, preservation and support of human cells, tissues and organs. The company supplies media and related disposables, which are used by laboratories and hospitals performing fertility treatment and other therapies where cells or tissues are used or are a part of the therapy. It offers optimized solutions for organ, tissue and cell preservation in connection with transplantation. The company operates in Sweden and the US. Vitrolife is headquartered in Gothenburg, Vastra Gotaland, Sweden.

Vitrolife AB Key Recent Developments

Feb 25,2019: Information from Vitrolife’s Election Committee
Feb 08,2019: Vitrolife: Report on Operations 2018 – High profitability and good organic growth
Sep 12,2018: Vitrolife strengthens organization in business development
Jul 13,2018: Vitrolife: Interim report January – June 2018
Jun 28,2018: Vitrolife and GE Healthcare partner to improve assisted reproductive technology offerings

This comprehensive SWOT profile of Vitrolife AB provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Vitrolife AB including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Vitrolife AB – Key Information
Vitrolife AB – Overview
Vitrolife AB – Key Employees
Vitrolife AB – Key Employee Biographies
Vitrolife AB – Key Operational Heads
Vitrolife AB – Major Products and Services
Vitrolife AB – History
Vitrolife AB – Company Statement
Vitrolife AB – Locations And Subsidiaries
Vitrolife AB – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Vitrolife AB – Business Description
Vitrolife AB – Corporate Strategy
Vitrolife AB – SWOT Analysis
SWOT Analysis – Overview
Vitrolife AB – Strengths
Vitrolife AB – Weaknesses
Vitrolife AB – Opportunities
Vitrolife AB – Threats
Vitrolife AB – Key Competitors

Section 3 – Company Financial Performance Charts

Vitrolife AB – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Vitrolife AB, Key Information
Vitrolife AB, Key Ratios
Vitrolife AB, Share Data
Vitrolife AB, Major Products and Services
Vitrolife AB, History
Vitrolife AB, Key Employees
Vitrolife AB, Key Employee Biographies
Vitrolife AB, Key Operational Heads
Vitrolife AB, Other Locations
Vitrolife AB, Subsidiaries
Vitrolife AB, Key Manufacturing facilities
Vitrolife AB, Key Competitors
Vitrolife AB, SWOT Analysis
Vitrolife AB, Ratios based on current share price
Vitrolife AB, Annual Ratios
Vitrolife AB, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Vitrolife AB, Performance Chart
Vitrolife AB, Ratio Charts

★海外企業調査レポート[Vitrolife AB (VITR):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sangamo Therapeutics Inc (SGMO):製薬・医療:M&Aディール及び事業提携情報
    Summary Sangamo Therapeutics Inc (Sangamo), formerly Sangamo BioSciences Inc, is a clinical stage biotechnology company that focuses on the research, development and commercialization of engineered DNA-binding proteins (ZFPs) for gene regulation, cell therapy and therapeutic genome editing. Its prod …
  • Rockwell Collins Inc:企業のM&A・事業提携・投資動向
    Rockwell Collins Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Rockwell Collins Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Medical Prognosis Institute AS (MPI)-医療機器分野:企業M&A・提携分析
    Summary Medical Prognosis Institute A/S (MPI) is a precision medicine provider that offers cancer treatment solutions. The company offers DRP platforms that provide tools for rationalized drug development and personalized medicine. It offers lead compound selection, drug rescue repositioning repurpo …
  • BioSyent Inc (RX):企業の財務・戦略的SWOT分析
    Summary BioSyent Inc (BioSyent), formerly Hedley Technologies Inc is a specialty pharmaceutical company that offers in-licensing or acquiring innovative pharmaceutical products and technologies to enhance human health. The company’s products include Aguettant System for pre-filled syringes, FeraMAX …
  • Canadian Utilities Ltd (CU):石油・ガス:M&Aディール及び事業提携情報
    Summary Canadian Utilities Ltd (CUL), an ATCO company, is an electric utility. The company carries out electricity and natural gas distribution and transmission operations. It constructs and maintains electrical transmission and distribution lines and has stakes in generating plants through subsidia …
  • Ana Holdings Inc:企業のM&A・事業提携・投資動向
    Ana Holdings Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ana Holdings Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Shanghai Institute of Materia Medica Chinese Academy of Sciences-製薬・医療分野:企業M&A・提携分析
    Summary Shanghai Institute of Materia Medica Chinese Academy of Sciences (SIMM) is an educational research institute that offers research and development of traditional Chinese medicine. The institute provides solutions in the areas of drug discovery and drug development. It also provides studies of …
  • Applied Maths NV:医療機器:M&Aディール及び事業提携情報
    Summary Applied Maths NV (Applied Maths), a subsidiary of bioMerieux SA, is a bioinformatics company that designs, develops and markets bioscience software products. The company offers software products such as bionumerics, gelcompar II, bionumerics server and bionumerics calculation engine. Its bio …
  • Daimler AG (DAI):企業の財務・戦略的SWOT分析
    Daimler AG (DAI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Duke Energy Indiana LLC:企業の戦略的SWOT分析
    Duke Energy Indiana LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • CardioFocus Inc-医療機器分野:企業M&A・提携分析
    Summary CardioFocus Inc (CardioFocus) is a medical device company that manufactures and distributes investigating disposable fiber optic catheters and endoscopic products. The company provides cardiofocus endoscopic ablation system that consists of balloon catheter, deflectable sheath introducer, en …
  • Hikma Pharmaceuticals Plc (HIK):企業の財務・戦略的SWOT分析
    Hikma Pharmaceuticals Plc (HIK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • transcosmos Inc:企業の戦略・SWOT・財務分析
    transcosmos Inc - Strategy, SWOT and Corporate Finance Report Summary transcosmos Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Adcock Ingram Holdings Ltd (AIP):製薬・医療:M&Aディール及び事業提携情報
    Summary Adcock Ingram Holdings Ltd (Adcock Ingram) develops, distributes and markets a wide range of healthcare products. The company’s product portfolio includes consumer and over-the-counter (OTC) products; prescription products; and generic medicines. It provides medicines in the areas of cardiov …
  • Odakyu Electric Railway Co., Ltd. (9007):企業の財務・戦略的SWOT分析
    Odakyu Electric Railway Co., Ltd. (9007) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Bankinter, S.A.:企業のM&A・事業提携・投資動向
    Bankinter, S.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Bankinter, S.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Berg LLC:医療機器:M&Aディール及び事業提携情報
    Summary Berg LLC (Berg) is a biopharmaceutical company that focus on therapeutic discovery using AI-based Interrogative biology platform. The company’s proprietary platform Interrogative Biology, combines patient biology and artificial intelligence-based analytics to understand predictive patterns o …
  • The Madison Square Garden Co:企業の戦略・SWOT・財務情報
    The Madison Square Garden Co - Strategy, SWOT and Corporate Finance Report Summary The Madison Square Garden Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Soft Tissue Regeneration Inc-医療機器分野:企業M&A・提携分析
    Summary Soft Tissue Regeneration Inc (STR) is a medical device company that develops technology for soft tissue regeneration of the anterior cruciate ligament of the knee. The company concentrates on the application of resorbable polymer scaffold technology to regenerate and repair ligament and tend …
  • Eurobank Ergasias SA:企業のM&A・事業提携・投資動向
    Eurobank Ergasias SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Eurobank Ergasias SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆